Compare ImmunityBio Inc. Common Stock (IBRX) vs Newegg Commerce Inc (NEGG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ImmunityBio Inc. Common Stock vs Newegg Commerce Inc — how do they compare? ImmunityBio Inc. Common Stock trades at $10.03 (market cap $10.51B), while Newegg Commerce Inc trades at $11.51 (market cap $243.30M). The key difference: ImmunityBio Inc. Common Stock is far larger — about 43.2× Newegg Commerce Inc's market cap, and ImmunityBio Inc. Common Stock is trading nearer its 52-week high, Newegg Commerce Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold ImmunityBio Inc. Common Stock for 0 Days and Newegg Commerce Inc for 14 Days on average.
| IBRX | NEGG | |
|---|---|---|
Market Cap | $10.51B | $243.30M |
Volume | 10,445,785 | 41,252 |
Sector | Health | Consumer Cyclical |
52-Week High | $11.55 | $92.74 |
52-Week Low | $1.98 | $11.49 |
Typical Hold Time | 0 Days | 14 Days |
Enterprise Value | $10.97B | $213.53M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
NEGG trades at $12.01, up 0.84% today. The stock faces a bearish technical signal with moving averages indicating selling pressure, though oscillators are neutral. Fundamentally, revenue was $1.44 billion in 2025 with a net loss of $4.88 million, but recent quarters show earnings beats. The company is expanding partnerships, such as with Western Digital for AI storage solutions (Business Wire, 2026-09-24).
The outlook is mixed. Positive earnings momentum and strategic partnerships offer growth potential, but negative operating cash flow, high debt-to-asset ratios, and insider selling pose risks. Analyst consensus is a buy with a $7.75 price target, below the current price, suggesting caution. Investors should weigh improving profitability against liquidity concerns and market volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About ImmunityBio Inc. Common Stock
ImmunityBio develops immune-based therapies for cancer and infectious diseases. Its programs are designed to activate and strengthen the body’s immune response.
Read more on IBRX →About Newegg Commerce Inc
Newegg Commerce Inc is an e-commerce company offering direct sales and an online marketplace platform for IT computer components, consumer electronics, entertainment, smart home and gaming products and provides certain third-party logistics services globally.
Read more on NEGG →
